Corient Capital Partners, LLC Sarepta Therapeutics, Inc. Transaction History

Corient Capital Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$63.15 - $90.42 $182,629 - $261,494	-2,892 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$77.28 - $99.42 $25,734 - $33,106	333 Added 13.01%	2,892 $261,000
Q3 2021 Nov 16, 2021	BUY	$65.97 - $92.48 $168,817 - $236,656	2,559 New	2,559 $237,000
Q1 2021 May 17, 2021	SELL	$72.25 - $168.95 $87,639 - $204,936	-1,213 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$125.56 - $178.74 $152,304 - $216,811	1,213 New	1,213 $206,000

529

84.2M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.4B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Corient Capital Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Corient Capital Partners, LLC with notifications on news.